Heavyweights

Heavyweights By Lev Facher

Eric Lander is brilliant, connected, and controversial. Now Joe Biden wants him to ‘reinvigorate’ American science

Heavyweights By Nicholas Florko

A former FDA chief, brimming with experience but lacking in niceties, surprises Washington by winning Biden’s trust

Heavyweights By Usha Lee McFarling

A ‘duty to warn’: An ER doctor, shaped by war and hardship, chronicles the searing realities of Covid-19

Heavyweights By Eric Boodman

As a kid, his factory work paid for his dad’s cancer care. As an oncologist, his research offers more than survival

Heavyweights By Matthew Herper

In the race for a Covid-19 vaccine, Pfizer turns to a scientist with a history of defying skeptics — and getting results

Heavyweights By Rebecca Robbins

Priscilla Chan charts an ambitious, unglamorous course to fight disease. (Her husband is involved, too.)

Heavyweights By Rebecca Robbins

Billionaire Sean Parker is nerding out on cancer research. Science has never seen anyone quite like him

Exclusive By Matthew Herper

One of the world’s best drug hunters went after Alzheimer’s. Here’s how he lost

Heavyweights By Rick Berke

Billionaire Sean Parker calls China’s gene-edited babies ‘Sputnik 2.0,’ praises FDA, and offers career advice for millennials

Heavyweights By Andrew Joseph

Elijah Cummings sparred with Martin Shkreli and Mylan’s CEO. Now he’s got a gavel to take on pharma

Heavyweights By Sharon Begley

A pioneer in cancer immunotherapy sees a future where vaccines, CAR-T, and checkpoint inhibitors come together

Heavyweights By Ed Silverman and Kate Sheridan

How Pfizer’s CEO flew under the political radar with price hikes — until he tangled with Trump

Heavyweights By Rob Waters

Her bio reads like Silicon Valley fan fiction. At 23, she’s investing millions in the quest to defy death

Heavyweights By Andrew Joseph

He takes on Eric Lander, and the scientific establishment. ‘This is who I am. I get angry.’

Heavyweights By Megan Thielking

Meet Nature’s new editor: a geneticist who reads scientific papers like ‘page turners’

Heavyweights By Helen Branswell

The virus hunter: In a bygone era, C.J. Peters learned how to bend the rules

Heavyweights By Andrew Joseph

A veteran New York litigator is taking on opioid makers. They have a history

Heavyweights By Sharon Begley

Not just for CRISPR: Lemelson-MIT Prize honors Feng Zhang for ‘big ideas that change fields’

Heavyweights By Usha Lee McFarling

The creator of the pig-human chimera keeps proving other scientists wrong

Heavyweights By Meghana Keshavan

Armed with science (and snark), a gynecologist takes on Trump, Goop, and all manner of bizarre health trends

First Opinion By Margaret Chan

My decade leading the WHO: dirty fights and steps toward universal coverage

Heavyweights By Sharon Begley

CRISPR pioneer Doudna envisions a world of woolly mammoths and unicorns

Heavyweights By Sharon Begley

‘A feature, not a bug’: George Church ascribes his visionary ideas to narcolepsy

Heavyweights By Eric Boodman

Andy Slavitt can’t stop: How a health care wonk became a rabble-rouser

Heavyweights By Bryan Marquard and Robert Weisman — Boston Globe

Most Read

At the top of her field, a Covid-19 researcher fights back against a different kind of virus: sexism and power imbalances in science

How Joe Grogan, a former pharma lobbyist, upended Trump’s drug pricing agenda

The entrepreneur behind the cancer immunotherapy revolution

‘I really don’t know what happened to Jim’: Friends ask where James Watson’s odious attitudes about race came from

Out of prison, the ‘father of gene therapy’ faces a harsh reality: a tarnished legacy and an ankle monitor

It’s not ‘all in your head’: When other doctors give up on patients, a boundary-breaking neurologist treats them

Near the campus cow pasture, a scientist works to grow human organs — in pigs

Did he really just tweet that? Dr. Vinay Prasad takes on Big Pharma, Big Medicine, and his own colleagues — with glee

All Coverage

Eric Lander is brilliant, connected, and controversial. Now Joe Biden wants him to ‘reinvigorate’ American science

A former FDA chief, brimming with experience but lacking in niceties, surprises Washington by winning Biden’s trust

A ‘duty to warn’: An ER doctor, shaped by war and hardship, chronicles the searing realities of Covid-19

As a kid, his factory work paid for his dad’s cancer care. As an oncologist, his research offers more than survival

In the race for a Covid-19 vaccine, Pfizer turns to a scientist with a history of defying skeptics — and getting results

Priscilla Chan charts an ambitious, unglamorous course to fight disease. (Her husband is involved, too.)

Billionaire Sean Parker is nerding out on cancer research. Science has never seen anyone quite like him

One of the world’s best drug hunters went after Alzheimer’s. Here’s how he lost

Billionaire Sean Parker calls China’s gene-edited babies ‘Sputnik 2.0,’ praises FDA, and offers career advice for millennials

Elijah Cummings sparred with Martin Shkreli and Mylan’s CEO. Now he’s got a gavel to take on pharma

A pioneer in cancer immunotherapy sees a future where vaccines, CAR-T, and checkpoint inhibitors come together

How Pfizer’s CEO flew under the political radar with price hikes — until he tangled with Trump

Her bio reads like Silicon Valley fan fiction. At 23, she’s investing millions in the quest to defy death

He takes on Eric Lander, and the scientific establishment. ‘This is who I am. I get angry.’

Meet Nature’s new editor: a geneticist who reads scientific papers like ‘page turners’

The virus hunter: In a bygone era, C.J. Peters learned how to bend the rules

A veteran New York litigator is taking on opioid makers. They have a history

Not just for CRISPR: Lemelson-MIT Prize honors Feng Zhang for ‘big ideas that change fields’

The creator of the pig-human chimera keeps proving other scientists wrong

Armed with science (and snark), a gynecologist takes on Trump, Goop, and all manner of bizarre health trends

My decade leading the WHO: dirty fights and steps toward universal coverage

CRISPR pioneer Doudna envisions a world of woolly mammoths and unicorns

‘A feature, not a bug’: George Church ascribes his visionary ideas to narcolepsy

Andy Slavitt can’t stop: How a health care wonk became a rabble-rouser

Henri Termeer, biotech leader who built Genzyme into an industry giant, dies at 71